A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache
Clinical trial NCT03107052 · TERMINATED
Trial details
- NCT number
- NCT03107052
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-27
- Primary completion
- 2019-06-11
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.